- This guy controls 62% of Singapore's market share.
- Has more than 35,000 units of cord blood banked in Singapore and Hong Kong.
- There are only 7 authorised cord blood banks in China and the country only allows each province to have a single licensed cord blood bank. And this guy owns a 10% stake in a PRC cord blood bank in Guangdong, the only foreign entity to have an equity stake in a Chinese cord blood bank.
- Most probably I will store my kids' cord blood with them someday.
- Intend to raise S$26.3mil net proceeds from its IPO, issue 60mil shares @ S$0.495: 58mil placement/2mil public.
- June year end, will pay out at least 25% of FY2011's S$8.5mil NP as dividend.
- S$16.6mil to expand market in Singapore and Hong Kong and fund acquisition in Indonesia, India and the Philipines.
- S$3mil to renovate its HQ at Yishun to house 650,000 cord blood units, more than 10 times of its current capacity.
- The rest for working cap, i reckon.
Say I buy Cordlife's share at 49.5 cents now and somewhere in October it pays out the S$2.13mil dividend, so per share I will be receiving 3.55 cents, which is a pleasing 7.17% DY without considering its upsides. And if this guy sort of plunges after listing, I will be ready to pump in my reserve to buy up more - this will increase the DY.
Think I better head down to one of the POSB ATMs today to apply for some shares and keep my fingers crossed.
Disclaimer: This is not an invitation to buy or sell. I do not guarantee the accuracy or validity of the information above. Do your own due diligence before investing and invest at your own risk.